Vortex Biosciences Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.45M

  • Investors
  • 2

Vortex Biosciences General Information

Description

Developer of a cancer diagnostic instrument designed to improve therapeutic decisions and save lives. The company's device offers a liquid biopsy automated instrument and microfluidic cartridge for the isolation of circulating tumor cells from whole blood without the need for any pre-treatment, enabling healthcare institutions and medical professionals with a collection efficiency of intact circulating tumor cells in less time.

Contact Information

Website
www.vortexctc.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 2 & 2A Enterprise House
  • Lloyd Street North
  • Manchester M15 6SE
  • England, United Kingdom
Primary Industry
Diagnostic Equipment
Vertical(s)
LOHAS & Wellness, Life Sciences, Oncology
Corporate Office
  • Unit 2 & 2A Enterprise House
  • Lloyd Street North
  • Manchester M15 6SE
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vortex Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 22-Jun-2023 $3.45M Completed Generating Revenue
4. Buyout/LBO (Secondary) 22-Apr-2019 Completed Generating Revenue
3. Early Stage VC (Series A) 25-May-2017 Cancelled Startup
2. Merger/Acquisition Completed Startup
1. University Spin-Out 01-Jan-2012 Completed Startup
To view Vortex Biosciences’s complete valuation and funding history, request access »

Vortex Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a cancer diagnostic instrument designed to improve therapeutic decisions and save lives. The company's devi
Diagnostic Equipment
Manchester, United Kingdom
11 As of 2023

New Haven, CT
 

Seattle, WA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vortex Biosciences Competitors (17)

One of Vortex Biosciences’s 17 competitors is Aliko Scientific, a Formerly PE-Backed company based in New Haven, CT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aliko Scientific Formerly PE-Backed New Haven, CT
RareCyte Venture Capital-Backed Seattle, WA
Nucleix Venture Capital-Backed Rehovot, Israel
Foundation Medicine Formerly VC-backed Boston, MA
Myriad Genetics Corporation Salt Lake City, UT
You’re viewing 5 of 17 competitors. Get the full list »

Vortex Biosciences Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Vortex Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200070167-A1 Processing systems for isolating and enumerating cells or particles Inactive 31-Aug-2018
WO-2017181186-A1 Microfluidic chips and cartridges and systems utilizing microfluidic chips and cartridges Inactive 15-Apr-2016

Vortex Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vortex Biosciences Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
EMV Capital Venture Capital Minority
University of California, Los Angeles University
To view Vortex Biosciences’s complete investors history, request access »

Vortex Biosciences Investments (1)

Vortex Biosciences’s most recent deal was a Corporate Asset Purchase with Harvard University (4 Patent Licences). The deal was made on 03-Aug-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Harvard University (4 Patent Licences) 03-Aug-2016 Corporate Asset Purchase Buildings and Property
To view Vortex Biosciences’s complete investments history, request access »

Ready to get started?

Request a free trial

Vortex Biosciences FAQs

  • When was Vortex Biosciences founded?

    Vortex Biosciences was founded in 2012.

  • Where is Vortex Biosciences headquartered?

    Vortex Biosciences is headquartered in Manchester, United Kingdom.

  • What is the size of Vortex Biosciences?

    Vortex Biosciences has 11 total employees.

  • What industry is Vortex Biosciences in?

    Vortex Biosciences’s primary industry is Diagnostic Equipment.

  • Is Vortex Biosciences a private or public company?

    Vortex Biosciences is a Private company.

  • What is Vortex Biosciences’s current revenue?

    The current revenue for Vortex Biosciences is .

  • How much funding has Vortex Biosciences raised over time?

    Vortex Biosciences has raised $3.45M.

  • Who are Vortex Biosciences’s investors?

    EMV Capital and University of California, Los Angeles have invested in Vortex Biosciences.

  • Who are Vortex Biosciences’s competitors?

    Aliko Scientific, RareCyte, Nucleix, Foundation Medicine, and Myriad Genetics are some of the 17 competitors of Vortex Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process